Accelera Innovations, Inc
ACNVOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8141
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Accelera Innovations, Inc (ACNV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ACNV · earnings · updated Jun 8, 2026
Latest Earnings
Q3 FY2017Report Date: Sep 30, 2017EPS Actual
-$0.00
Revenue
—
Fiscal Period
Q3 FY2017
FY ends December
Report Date
Sep 30, 2017
After Market Close
ACNV reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2017 | Sep 30, 2017 | — | -$0.00 | — | — | — | — |
| — Q3 FY2017 | Aug 11, 2017 | — | -$0.00 | — | — | — | — |
| — Q1 FY2017 | Mar 31, 2017 | — | -$0.00 | — | — | — | — |
| — Q4 FY2016 | Dec 31, 2016 | — | -$0.08 | — | $0.00B | — | — |
| — Q4 FY2016 | Nov 21, 2016 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2016 | Jun 30, 2016 | — | -$0.01 | — | — | — | — |
| — Q1 FY2016 | Mar 31, 2016 | — | $0.08 | — | — | — | — |
| — Q4 FY2015 | Dec 31, 2015 | — | -$0.04 | — | $0.00B | — | — |
Q3 FY2017
Sep 30, 2017
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2017
Aug 11, 2017
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2017
Mar 31, 2017
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2016
Dec 31, 2016
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2016
Nov 21, 2016
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2016
Jun 30, 2016
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2016
Mar 31, 2016
EPS Actual
$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2015
Dec 31, 2015
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for ACNV.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2017 | Sep 30, 2017 | — | $0.00 | $0.00 | +11.54% |
| — Q3 FY2017 | Aug 11, 2017 | — | $0.00 | $0.00 | -8.57% |
| — Q1 FY2017 | Mar 31, 2017 | — | $0.00 | $0.00 | +0.00% |
| — Q4 FY2016 | Dec 31, 2016 | — | $0.01 | $0.01 | +7.84% |
| — Q4 FY2016 | Nov 21, 2016 | — | $0.01 | $0.01 | -14.53% |
| — Q2 FY2016 | Jun 30, 2016 | — | $0.07 | $0.07 | +0.00% |
| — Q1 FY2016 | Mar 31, 2016 | — | $0.10 | $0.12 | +26.32% |
| — Q4 FY2015 | Dec 31, 2015 | — | $0.14 | $0.14 | +3.68% |
Q3 FY2017+11.54%
Report Date
Sep 30, 2017
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2017-8.57%
Report Date
Aug 11, 2017
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q1 FY2017+0.00%
Report Date
Mar 31, 2017
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2016+7.84%
Report Date
Dec 31, 2016
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2016-14.53%
Report Date
Nov 21, 2016
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2016+0.00%
Report Date
Jun 30, 2016
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q1 FY2016+26.32%
Report Date
Mar 31, 2016
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.12
Q4 FY2015+3.68%
Report Date
Dec 31, 2015
EPS Beat/Miss
—
Price Before
$0.14
Price After
$0.14
Beat Rate0 / 8 quarters
Largest Move+26.32% (Q1 FY2016)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ACNV ends December
Accelera Innovations, Inc (ACNV) most recently reported earnings on September 30, 2017 for Q3 FY2017, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ACNV earnings date is expected around September 1, 2026.
Each quarter, investors track ACNV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ACNV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ACNV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ACNV earnings · 4 questionsAccelera Innovations, Inc's next earnings report is expected around September 1, 2026. ACNV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ACNV historically reports after market close (AMC).
ACNV earnings datewhen is ACNV earningsACNV next earnings datewhen does ACNV report earningsACNV earnings calendar
▸ Source: FMP · Accelera Innovations, Inc SEC filings · US GAAP · Accelera Innovations, Inc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026